Trials
2 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Malignant Pleural Effusions (Mpe) (2 trials)
- Main trialPhase 2
- “This study aims to evaluate the efficacy and safety of intrapleural JMKX000197 compared with intrapleural cisplatin in patients with malignant pleural effusion.”In the company’s words, NCT07649369 on ClinicalTrials.gov
Other drugs for Malignant Pleural Effusions (Mpe)
Coming up1
- 12 Jan 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 12 Jan 2028 | A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion | |
| Phase 1Recruiting | 31 Dec 2025 | A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion | |
| Phase 1Unknown | 30 Apr 2025 | A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026